Impact of ventricular assist device placement on longitudinal renal function in children with end-stage heart failure

被引:19
|
作者
May, Lindsay J. [1 ]
Montez-Rath, Maria E. [2 ]
Yeh, Justin [3 ]
Axelrod, David M. [4 ]
Chen, Sharon [4 ]
Maeda, Katsuhide [5 ]
Almond, Christopher S. D. [4 ]
Rosenthal, David N. [4 ]
Hollander, Seth A. [4 ]
Sutherland, Scott M. [6 ]
机构
[1] Univ Utah, Sch Med, Dept Pediat, Div Pediat Cardiol, Salt Lake City, UT USA
[2] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Palo Alto, CA 94304 USA
[3] Univ Calif San Diego, Dept Pediat, Div Pediat Cardiol, La Jolla, CA 92093 USA
[4] Stanford Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Palo Alto, CA 94304 USA
[5] Stanford Univ, Dept Cardiothorac Surg, Div Pediat Cardiac Surg, Palo Alto, CA 94304 USA
[6] Stanford Univ, Sch Med, Dept Pediat, Div Pediat Nephrol, Palo Alto, CA 94304 USA
来源
关键词
ventricular assist device; end-organ dysfunction; renal function; children; end-stage heart failure; ACUTE KIDNEY INJURY; MECHANICAL CIRCULATORY SUPPORT; GLOMERULAR-FILTRATION-RATE; CONTINUOUS-FLOW; CARDIAC-SURGERY; CARDIORENAL SYNDROME; OUTCOMES; TRANSPLANTATION; IMPLANTATION; RISK;
D O I
10.1016/j.healun.2015.10.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Although ventricular assist devices (VADs) restore hemodynamics in those with heart failure, reversibility of end-organ dysfunction with VAD support is not well characterized. Renal function often improves in adults after VAD placement, but this has not been comprehensively explored in children. METHODS: Sixty-three children on VAD support were studied. Acute kidney injury (AKI) was defined by Kidney Disease: Improving Global Outcomes criteria. Estimated glomerular filtration rate (eGFR) was determined by the Schwartz method. Generalized linear mixed-effects models compared the pre-VAD and post-VAD eGFR for the cohort and sub-groups with and without pre-VAD renal dysfunction (pre-VAD eGFR < 90 ml/min/1.73 m(2)). RESULTS: The pre-VAD eGFR across the cohort was 84.0 ml/min/1.73 m(2) (interquartile range [IQR] 62.3-122.7), and 55.6% (34 of 63) had pre-VAD renal dysfunction. AKI affected 60.3% (38 of 63), with similar rates in those with and without pre-existing renal dysfunction. Within the cohort, the nadir eGFR occurred 1 day post-operatively (62.9 ml/min/1.73 m(2); IQR, 51.2-88.9 ml/min/1.73 m(2); p < 0.001). By Day 5, however, the eGFR exceeded the baseline (99.0 ml/min/1.73 m(2); IQR, 59.3-146.7 ml/min/1.73 m(2); p = 0.03) and remained significantly higher through the first post-operative week. After adjusting for age, gender, and AKI, the eGFR continued to increase throughout the entire 180-day study period (beta = 0.0025; 95% confidence interval, 0.0015-0.0036; p < 0.001). Patients with pre-VAD renal dysfunction experienced the greatest improvement in the eGFR (beta = 0.0051 vs beta = 0.0013, p < 0.001). CONCLUSIONS: Renal dysfunction is prevalent in children with heart failure undergoing VAD placement. Although peri-operative AKI is common, renal function improves substantially in the first post-operative week and for months thereafter. This is particularly pronounced in those with pre-VAD renal impairment, suggesting that VADs may facilitate recovery and maintenance of kidney function in children with advanced heart failure. (C) 2016 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:449 / 456
页数:8
相关论文
共 50 条
  • [1] Outcomes and Trends of Ventricular Assist Device Selection in Children with End-Stage Heart Failure
    Miller, Jacob R.
    Lancaster, Timothy S.
    Epstein, Deirdre J.
    DuPont, Nicholas C.
    Simpson, Kathleen E.
    Castleberry, Chesney
    Canter, Charles E.
    Eghtesady, Pirooz
    Boston, Umar S.
    [J]. ASAIO JOURNAL, 2017, 63 (04) : 464 - 469
  • [2] Development of a Pacemaker with a Ventricular Assist Device for End-Stage Heart Failure Patients
    Kim, Yoo Seok
    Park, Sung Min
    Choi, Seong Wook
    [J]. TRANSACTIONS OF THE KOREAN SOCIETY OF MECHANICAL ENGINEERS B, 2011, 35 (11) : 1205 - 1211
  • [3] Impact of Contemporary Ventricular Assist Device Therapy on Renal Outcomes in End Stage Heart Failure
    Xu, P. Z.
    Wu, S.
    Tun, H.
    Adenuga, G.
    Fong, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S473 - S474
  • [4] A Novel Percutaneons Right Ventricular Assist Device for End-stage Heart Failure
    Takayama, Hiroo
    Naka, Yoshifumi
    Kodali, Susheel K.
    Vincent, Julie A.
    Addonizio, Linda J.
    Jorde, Ulrich P.
    Williams, Mathew R.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B71 - B71
  • [5] Left Ventricular Assist Device Therapy for Treatment of End-Stage Heart Failure
    Seelandt, Katherine K.
    Farnsworth, Monica M.
    [J]. JOURNAL OF CONTINUING EDUCATION IN NURSING, 2009, 40 (04): : 150 - 151
  • [6] Stability of Cardiac Function after Left Ventricular Assist Device Weaning in End-Stage Heart Failure
    Taleb, I.
    Yin, M.
    Koliopoulou, A.
    Kyriakopoulos, C. P.
    Nativi-Nicolau, J.
    Wever-Pinzon, O.
    McKellar, S. H.
    Dranow, E.
    Stehlik, J.
    Gilbert, E. M.
    Fang, J. C.
    Selzman, C. H.
    Drakos, S. G.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S349 - S349
  • [7] Implanting left ventricular assist device in end-stage heart failure with massive ventricular aneurysm
    Yao, Shaowen
    Qin, Yannv
    Yue, Jiarui
    Lu, Shichun
    [J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (07) : 3332 - 3334
  • [8] Ventricular Assist Device Support in End-Stage Heart Failure From Cardiac Amyloidosis
    Lim, Choon Pin
    Lim, Yeong Phang
    Lim, Chong Hee
    Ong, Hean Yee
    Tan, Daryl
    Chew, Huck Chin
    Omar, Abdul Razakjr
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2019, 48 (12) : 435 - 438
  • [9] Ventricular Assist System Applications in End-stage Heart Failure
    Yagdi, T.
    Oguz, E.
    Ayik, F.
    Ertugay, S.
    Nalbantgil, S.
    Engin, C.
    Ozbaran, M.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (03) : 923 - 926
  • [10] Innovations in Ventricular Assist Devices for End-Stage Heart Failure
    Miller, Robert J. H.
    Teuteberg, Jeffrey J.
    Hunt, Sharon A.
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 33 - 44